期刊
PARKINSONISM & RELATED DISORDERS
卷 16, 期 2, 页码 85-88出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2009.10.004
关键词
LRRK2; G2385R; R1628P; Parkinson's disease; Polymorphism
资金
- Ministry of Health & Welfare, Republic of Korea [A030001]
- Seoul National University Bundang and Borame Municipal Hospital [02-2009-017, 03-2008-11]
The G2385R (SNP accession no. rs34778348) and R1628P (rs33949390) variants Of leucine-rich repeat kinase 2 (LRRK2, PARK8) are emerging as an important risk factor for Parkinson's disease (PD) in the ethnic Chinese and Japanese Populations. The purpose of this study was to investigate whether these variants are a genetic risk factor in sporadic PD patients in the Korean population. A total of 923 patients and 422 healthy subjects were included. The variants were screened by a SNaPshot assay. The LRRK2 G2385R variant was detected in 82 PD patients (8.9%, two homozygous and 80 heterozygous) and in 21 normal controls (5.0%, all heterozygous). The frequency of the LRRK2 G2385R variant in PD was significantly higher than in normal controls (adjusted odds ratio 1.83, p = 0.0170, 95% confidence interval 1.11-3.00). There were no differences in the mean age at onset or gender between the G2385R carriers and the non-carriers in PD patients. The LRRK2 R1628P variant was very rare (0.78% in patients versus 0.26% in controls) in the tested 384 patient-control pairs, and was not a significant risk factor. This Study Supports that the LRRK2 G2385R variant may be a genetic risk factor for sporadic PD in the Korean population. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据